EDAP Stock Analysis: Buy, Sell, or Hold?
EDAP - EDAP TMS SA
$4.16
0.57 (15.72%)
▲
5d:
+25.3%
30d:
+23.44%
90d:
+4.0%
HOLD
MODERATE Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When EDAP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: EDAP is 14.9% above its trading range ($3.62). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: EDAP is 14.9% above its trading range ($3.62). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: EDAP is currently trading at $4.16, which is considered extended relative to its 30-day fair value range of $3.26 to $3.62.
Technical Outlook: Technically, EDAP is showing sideways momentum. The price is approaching resistance at $4.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 15.7% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.50 (+32.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EDAP is showing sideways momentum. The price is approaching resistance at $4.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 15.7% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.50 (+32.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.26 -
$3.62
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
45.8%
All Signals
- BEARISH: Price significantly overextended (+14.9% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+15.7%)
- BULLISH: Trading 32.2% below Wall St target ($5.50)
Trading Range Analysis
30-Day Trading Range
$3.26 -
$3.62
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.15
Resistance Level
$4.25
Current Trend
Sideways
Technical data as of
May 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.43
Wall Street Target
$5.50
(+32.2%)
Revenue Growth (YoY)
-19.0%
Earnings Growth (YoY)
-62.2%
Profit Margin
-41.5%
Share & Embed Analysis
Last updated: May 08, 2026 7:08 AM ET
Data refreshes hourly during market hours. Next update: 8:08 AM
Data refreshes hourly during market hours. Next update: 8:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EDAP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$248 | 61 BUY |
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$991 | 48 HOLD |
|
COR
Cencora Inc. |
BUY
17 analysts |
$403 | 50 HOLD |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$90 | 59 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
